PUBLISHER: The Business Research Company | PRODUCT CODE: 1949692
PUBLISHER: The Business Research Company | PRODUCT CODE: 1949692
Advanced Therapy Medicinal Products Global Market Report 2026
Advanced therapy medicinal products are treatments developed using genes, cells, or tissue engineering approaches that provide innovative solutions for a wide variety of diseases and injuries. These therapies function by repairing, replacing, or regenerating human cells, tissues, or organs in order to restore normal biological function.
The main product types of advanced therapy medicinal products include somatic cell therapy medicinal products, tissue-engineered medicinal products, and gene therapy medicinal products. Somatic cell therapy medicinal products involve the use of human cells, excluding reproductive cells, that are manipulated or processed to treat, prevent, or cure diseases by repairing or replacing damaged cells or tissues. These therapies employ a range of technologies, including gene editing technologies, viral vector technology, stem cell technology, and automation and artificial intelligence-driven processes. They are used to treat various conditions such as muscular dystrophies, Alzheimer's disease, hemophilia, cystic fibrosis, and other applications. These products are distributed through channels including hospital pharmacies, retail pharmacies, and online pharmacies, serving a wide range of end users such as hospitals, specialty clinics, and other end users.
Tariffs have affected the advanced therapy medicinal products market by increasing the cost of imported raw materials, viral vectors, and stem cell processing equipment. Segments like gene therapy medicinal products and tissue-engineered products are particularly impacted, with major effects in regions such as Europe and Asia-Pacific, including China and India. This has led to higher production costs and potential delays in therapy availability. On the positive side, tariffs have encouraged local manufacturing, boosted domestic innovation, and promoted investments in regional production facilities.
The advanced therapy medicinal products market research report is one of a series of new reports from The Business Research Company that provides advanced therapy medicinal products market statistics, including advanced therapy medicinal products industry global market size, regional shares, competitors with a advanced therapy medicinal products market share, detailed advanced therapy medicinal products market segments, market trends and opportunities, and any further data you may need to thrive in the advanced therapy medicinal products industry. This advanced therapy medicinal products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The advanced therapy medicinal products market size has grown rapidly in recent years. It will grow from $51.34 billion in 2025 to $61.41 billion in 2026 at a compound annual growth rate (CAGR) of 19.6%. The growth in the historic period can be attributed to limited availability of advanced therapy products, reliance on traditional biologics, nascent regulatory frameworks, high cost of gene and cell therapies, limited distribution channels.
The advanced therapy medicinal products market size is expected to see rapid growth in the next few years. It will grow to $124.43 billion in 2030 at a compound annual growth rate (CAGR) of 19.3%. The growth in the forecast period can be attributed to technological advancements in gene editing and stem cell therapies, rising investment in personalized medicine, increasing prevalence of rare and chronic diseases, expansion of hospital pharmacy and specialty clinic networks, integration of ai-driven manufacturing and automation processes. Major trends in the forecast period include rising adoption of autologous and allogeneic therapies, expansion of gene editing and viral vector technologies, increasing focus on rare disease treatments, integration of automation in therapy manufacturing, growing hospital and specialty clinic collaborations.
The increasing demand for personalized medicine is anticipated to drive the growth of the advanced therapy medicinal products market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and prevention strategies based on an individual's genetic profile, lifestyle, and environmental factors. The growing demand for personalized medicine is mainly driven by the rising prevalence of chronic diseases, as personalized approaches allow for targeted therapies that enhance treatment effectiveness while minimizing adverse effects for patients. Advanced therapy medicinal products support personalized medicine by providing customized solutions such as gene therapies, cell therapies, and tissue-engineered treatments that address the specific genetic and biological characteristics of individual patients. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, it was reported that in 2023 the US Food and Drug Administration approved 16 new personalized treatments for patients with rare diseases, an increase from six approvals in 2022. The personalized therapies approved in 2023 also included seven cancer treatments and three therapies for other diseases and conditions. Therefore, the rising demand for personalized medicine is driving the growth of the advanced therapy medicinal products market.
Major companies operating in the advanced therapy medicinal products (ATMP) market are emphasizing the development of innovative therapies, such as gene-editing cell treatments, to deliver targeted and potentially curative solutions for disorders including B thalassemia and sickle cell disease. Gene-editing cell therapies involve harvesting a patient's hematopoietic stem cells and precisely modifying their genetic material outside the body, commonly using CRISPR Cas9 technology to correct disease-causing mutations or activate beneficial genetic pathways. This approach offers a personalized alternative to conventional allogeneic bone marrow transplantation, which depends on donor compatibility and carries risks such as graft-versus-host disease. For instance, in January 2024, Vertex Pharmaceuticals, a US-based biotechnology company, received approval from the US Food and Drug Administration for CASGEVY (exagamglogene autotemcel, or exa-cel), a CRISPR Cas9-based gene-editing cell therapy for transfusion-dependent B thalassemia. The therapy utilizes autologous CD34+ stem and progenitor cells and edits the erythroid-specific BCL11A enhancer to increase fetal hemoglobin production. Clinical studies have shown sustained therapeutic benefits, with the potential to achieve transfusion independence for many patients and substantially reduce or eliminate the need for ongoing blood transfusions.
In May 2024, Tri-Tech Forensics Inc., a US-based forensic services company, acquired SAM Medical Products for an undisclosed sum. This acquisition is expected to support Tri-Tech Forensics in expanding its emergency medical product portfolio and reinforcing its market position. SAM Medical Products is a US-based company that designs, manufactures, and markets orthopedic splints, wound care devices, and medical service products intended for a wide range of healthcare professionals.
Major companies operating in the advanced therapy medicinal products market are F. Hoffmann-La Roche Limited., Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited., Lonza Group AG, Catalent Inc., BioMarin Pharmaceutical Inc., AGC Biologics Inc., ViaCyte Inc., Rentschler Biopharma SE, JCR Pharmaceuticals Co. Ltd., Vericel Corporation, UniQure N.V., Fate Therapeutics Inc., WuXi Advanced Therapies Inc., Celonic Group AG, Pharmicell Co. Ltd., Magenta Therapeutics Inc, MEDIPOST Co. Ltd., Kolon TissueGene Inc
North America was the largest region in the advanced therapy medicinal products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the advanced therapy medicinal products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The advanced therapy medicinal products market consists of revenues earned by entities by providing services such as cell and gene therapy development services, viral vector production and characterization, regulatory and clinical trial support, analytical testing and quality control services, and process development and scale-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The advanced therapy medicinal products market also includes sales of gene therapy vectors, engineered tissue scaffolds, bioengineered skin substitutes, and encapsulated cell therapies. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Advanced Therapy Medicinal Products Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses advanced therapy medicinal products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for advanced therapy medicinal products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The advanced therapy medicinal products market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
- Markets Covered:1) By Product: Somatic Cell Therapy Medicinal Products; Tissue Engineered Medicinal Products; Gene Therapy Medicinal Products
- 2) By Technology: Gene Editing Technologies; Viral Vector Technology; Stem Cell Technology; Automation And Artificial Intelligence-Driven Processes
- 3) By Application: Muscular Dystrophies; Alzheimer's; Hemophilia; Cystic Fibrosis; Other Applications
- 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy
- 5) By End User: Hospitals; Specialty Clinics; Other End Users
- Subsegments:
- 1) By Somatic Cell Therapy Medicinal Products: Autologous Cell Therapy; Allogeneic Cell Therapy; Stem Cell Therapy; Dendritic Cell Therapy; Natural Killer Cell Therapy
- 2) By Tissue Engineered Medicinal Products: Autologous Tissue-Engineered Products; Allogeneic Tissue-Engineered Products; Scaffold-Based Tissue Engineering; Scaffold-Free Tissue Engineering; Skin Substitutes
- 3) By Gene Therapy Medicinal Products: In Vivo Gene Therapy; Ex Vivo Gene Therapy; Viral Vector-Based Gene Therapy; Non-Viral Vector-Based Gene Therapy; Gene Editing Therapies
- Companies Mentioned: F. Hoffmann-La Roche Limited.; Novartis AG; Bristol-Myers Squibb Company; Takeda Pharmaceutical Company Limited.; Lonza Group AG; Catalent Inc.; BioMarin Pharmaceutical Inc.; AGC Biologics Inc.; ViaCyte Inc.; Rentschler Biopharma SE; JCR Pharmaceuticals Co. Ltd.; Vericel Corporation; UniQure N.V.; Fate Therapeutics Inc.; WuXi Advanced Therapies Inc.; Celonic Group AG; Pharmicell Co. Ltd.; Magenta Therapeutics Inc; MEDIPOST Co. Ltd.; Kolon TissueGene Inc
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: Word, PDF or Interactive Report
- + Excel Dashboard
- Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
Table of Contents
1. Executive Summary
- 1.1. Key Market Insights (2020-2035)
- 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
- 1.3. Major Factors Driving the Market
- 1.4. Top Three Trends Shaping the Market
2. Advanced Therapy Medicinal Products Market Characteristics
- 2.1. Market Definition & Scope
- 2.2. Market Segmentations
- 2.3. Overview of Key Products and Services
- 2.4. Global Advanced Therapy Medicinal Products Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
- Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
- 2.4.4. Market Attractiveness Scoring and Interpretation
- 2.4.5. Strategic Implications and Recommendations
3. Advanced Therapy Medicinal Products Market Supply Chain Analysis
- 3.1. Overview of the Supply Chain and Ecosystem
- 3.2. List Of Key Raw Materials, Resources & Suppliers
- 3.3. List Of Major Distributors and Channel Partners
- 3.4. List Of Major End Users
4. Global Advanced Therapy Medicinal Products Market Trends And Strategies
- 4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Artificial Intelligence & Autonomous Intelligence
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.2. Major Trends
- 4.2.1 Rising Adoption Of Autologous And Allogeneic Therapies
- 4.2.2 Expansion Of Gene Editing And Viral Vector Technologies
- 4.2.3 Increasing Focus On Rare Disease Treatments
- 4.2.4 Integration Of Automation In Therapy Manufacturing
- 4.2.5 Growing Hospital And Specialty Clinic Collaborations
5. Advanced Therapy Medicinal Products Market Analysis Of End Use Industries
- 5.1 Hospitals
- 5.2 Specialty Clinics
- 5.3 Pharmaceutical And Biotechnology Companies
- 5.4 Research Institutions
- 5.5 Contract Research Organizations (Cros)
6. Advanced Therapy Medicinal Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Advanced Therapy Medicinal Products Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
- 7.1. Global Advanced Therapy Medicinal Products PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 7.2. Global Advanced Therapy Medicinal Products Market Size, Comparisons And Growth Rate Analysis
- 7.3. Global Advanced Therapy Medicinal Products Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
- 7.4. Global Advanced Therapy Medicinal Products Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Advanced Therapy Medicinal Products Total Addressable Market (TAM) Analysis for the Market
- 8.1. Definition and Scope of Total Addressable Market (TAM)
- 8.2. Methodology and Assumptions
- 8.3. Global Total Addressable Market (TAM) Estimation
- 8.4. TAM vs. Current Market Size Analysis
- 8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Advanced Therapy Medicinal Products Market Segmentation
- 9.1. Global Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Somatic Cell Therapy Medicinal Products, Tissue Engineered Medicinal Products, Gene Therapy Medicinal Products
- 9.2. Global Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Gene Editing Technologies, Viral Vector Technology, Stem Cell Technology, Automation And Artificial Intelligence-Driven Processes
- 9.3. Global Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Muscular Dystrophies, Alzheimer's, Hemophilia, Cystic Fibrosis, Other Applications
- 9.4. Global Advanced Therapy Medicinal Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Hospital Pharmacy, Retail Pharmacy
- 9.5. Global Advanced Therapy Medicinal Products Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Hospitals, Specialty Clinics, Other End Users
- 9.6. Global Advanced Therapy Medicinal Products Market, Sub-Segmentation Of Somatic Cell Therapy Medicinal Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy, Natural Killer Cell Therapy
- 9.7. Global Advanced Therapy Medicinal Products Market, Sub-Segmentation Of Tissue Engineered Medicinal Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Autologous Tissue-Engineered Products, Allogeneic Tissue-Engineered Products, Scaffold-Based Tissue Engineering, Scaffold-Free Tissue Engineering, Skin Substitutes
- 9.8. Global Advanced Therapy Medicinal Products Market, Sub-Segmentation Of Gene Therapy Medicinal Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- In Vivo Gene Therapy, Ex Vivo Gene Therapy, Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Gene Editing Therapies
10. Advanced Therapy Medicinal Products Market Regional And Country Analysis
- 10.1. Global Advanced Therapy Medicinal Products Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- 10.2. Global Advanced Therapy Medicinal Products Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Advanced Therapy Medicinal Products Market
- 11.1. Asia-Pacific Advanced Therapy Medicinal Products Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 11.2. Asia-Pacific Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Advanced Therapy Medicinal Products Market
- 12.1. China Advanced Therapy Medicinal Products Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 12.2. China Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Advanced Therapy Medicinal Products Market
- 13.1. India Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Advanced Therapy Medicinal Products Market
- 14.1. Japan Advanced Therapy Medicinal Products Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 14.2. Japan Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Advanced Therapy Medicinal Products Market
- 15.1. Australia Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Advanced Therapy Medicinal Products Market
- 16.1. Indonesia Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Advanced Therapy Medicinal Products Market
- 17.1. South Korea Advanced Therapy Medicinal Products Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 17.2. South Korea Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Advanced Therapy Medicinal Products Market
- 18.1. Taiwan Advanced Therapy Medicinal Products Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 18.2. Taiwan Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Advanced Therapy Medicinal Products Market
- 19.1. South East Asia Advanced Therapy Medicinal Products Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 19.2. South East Asia Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Advanced Therapy Medicinal Products Market
- 20.1. Western Europe Advanced Therapy Medicinal Products Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 20.2. Western Europe Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Advanced Therapy Medicinal Products Market
- 21.1. UK Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Advanced Therapy Medicinal Products Market
- 22.1. Germany Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Advanced Therapy Medicinal Products Market
- 23.1. France Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Advanced Therapy Medicinal Products Market
- 24.1. Italy Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Advanced Therapy Medicinal Products Market
- 25.1. Spain Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Advanced Therapy Medicinal Products Market
- 26.1. Eastern Europe Advanced Therapy Medicinal Products Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 26.2. Eastern Europe Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Advanced Therapy Medicinal Products Market
- 27.1. Russia Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Advanced Therapy Medicinal Products Market
- 28.1. North America Advanced Therapy Medicinal Products Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 28.2. North America Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Advanced Therapy Medicinal Products Market
- 29.1. USA Advanced Therapy Medicinal Products Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 29.2. USA Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Advanced Therapy Medicinal Products Market
- 30.1. Canada Advanced Therapy Medicinal Products Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 30.2. Canada Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Advanced Therapy Medicinal Products Market
- 31.1. South America Advanced Therapy Medicinal Products Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 31.2. South America Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Advanced Therapy Medicinal Products Market
- 32.1. Brazil Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Advanced Therapy Medicinal Products Market
- 33.1. Middle East Advanced Therapy Medicinal Products Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 33.2. Middle East Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Advanced Therapy Medicinal Products Market
- 34.1. Africa Advanced Therapy Medicinal Products Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 34.2. Africa Advanced Therapy Medicinal Products Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Advanced Therapy Medicinal Products Market Regulatory and Investment Landscape
36. Advanced Therapy Medicinal Products Market Competitive Landscape And Company Profiles
- 36.1. Advanced Therapy Medicinal Products Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
- 36.2. Advanced Therapy Medicinal Products Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
- 36.3. Advanced Therapy Medicinal Products Market Company Profiles
- 36.3.1. F. Hoffmann-La Roche Limited. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Takeda Pharmaceutical Company Limited. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
37. Advanced Therapy Medicinal Products Market Other Major And Innovative Companies
- Catalent Inc., BioMarin Pharmaceutical Inc., AGC Biologics Inc., ViaCyte Inc., Rentschler Biopharma SE, JCR Pharmaceuticals Co. Ltd., Vericel Corporation, UniQure N.V., Fate Therapeutics Inc., WuXi Advanced Therapies Inc., Celonic Group AG, Pharmicell Co. Ltd., Magenta Therapeutics Inc, MEDIPOST Co. Ltd., Kolon TissueGene Inc
38. Global Advanced Therapy Medicinal Products Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Advanced Therapy Medicinal Products Market
40. Advanced Therapy Medicinal Products Market High Potential Countries, Segments and Strategies
- 40.1 Advanced Therapy Medicinal Products Market In 2030 - Countries Offering Most New Opportunities
- 40.2 Advanced Therapy Medicinal Products Market In 2030 - Segments Offering Most New Opportunities
- 40.3 Advanced Therapy Medicinal Products Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies
41. Appendix
- 41.1. Abbreviations
- 41.2. Currencies
- 41.3. Historic And Forecast Inflation Rates
- 41.4. Research Inquiries
- 41.5. The Business Research Company
- 41.6. Copyright And Disclaimer
